Posted by Michael Wonder on 10 Apr 2021
Scilex has received from FDA a sNDA approval for ZTlido label expansion
9 April 2021 - Scilex has received a supplemental new drug application approval from the FDA for ZTlido to make efficacy labelling change with clinical data.
ZTlido is the only lidocaine topical system that has been studied under the water stress conditions, and now has FDA label reflecting its use while showering, swimming and bathing.
